Pms-Sodium Polystyrene Sulfonate and Zanamivir Inhalation, oral/nebulization
Determining the interaction of Pms-Sodium Polystyrene Sulfonate and Zanamivir Inhalation, oral/nebulization and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
Generic Name: zanamivir
Brand name: Relenza
Synonyms: Zanamivir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pms-Sodium Polystyrene Sulfonate-Zanosar
- Pms-Sodium Polystyrene Sulfonate-Zantac
- Pms-Sodium Polystyrene Sulfonate-Zantac (Ranitidine Injection)
- Pms-Sodium Polystyrene Sulfonate-Zantac (Ranitidine Syrup)
- Pms-Sodium Polystyrene Sulfonate-Zantac (Ranitidine Tablets and Capsules)
- Pms-Sodium Polystyrene Sulfonate-Zantac Cool Mint
- Zanamivir Inhalation, oral/nebulization-Pneumococcal 13-valent conjugate vaccine
- Zanamivir Inhalation, oral/nebulization-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Zanamivir Inhalation, oral/nebulization-Pneumococcal Conjugate Vaccine (13-Valent)
- Zanamivir Inhalation, oral/nebulization-Pneumococcal Conjugate Vaccine (7-Valent)
- Zanamivir Inhalation, oral/nebulization-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Zanamivir Inhalation, oral/nebulization-Pneumococcal polysaccharides vaccine (PPSV), 23-valent